Derivatives of alkyl gallate triphenylphosphonium exhibit antitumor activity in a syngeneic murine model of mammary adenocarcinoma
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
28647477
DOI
10.1016/j.taap.2017.06.017
PII: S0041-008X(17)30274-0
Knihovny.cz E-resources
- Keywords
- Alkyl gallate triphenylphosphonium derivatives, Delocalized lipophilic cation, Doxycycline, Syngeneic murine model of breast cancer, Uncoupling of mitochondrial function,
- MeSH
- Adenocarcinoma * drug therapy genetics metabolism pathology MeSH
- Adenosine Triphosphate metabolism MeSH
- Apoptosis drug effects MeSH
- Organelle Biogenesis MeSH
- Time Factors MeSH
- Doxycycline pharmacology MeSH
- Mammary Neoplasms, Experimental * drug therapy genetics metabolism pathology MeSH
- Caspase 3 metabolism MeSH
- Gallic Acid * analogs & derivatives pharmacology MeSH
- Mitochondria drug effects metabolism pathology MeSH
- Mice MeSH
- Cell Line, Tumor MeSH
- Organophosphorus Compounds * pharmacology MeSH
- Oxidative Phosphorylation drug effects MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents * pharmacology MeSH
- Antineoplastic Combined Chemotherapy Protocols pharmacology MeSH
- Signal Transduction drug effects MeSH
- Oxygen Consumption drug effects MeSH
- Tumor Burden drug effects MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adenosine Triphosphate MeSH
- Casp3 protein, mouse MeSH Browser
- Doxycycline MeSH
- Caspase 3 MeSH
- Gallic Acid * MeSH
- Organophosphorus Compounds * MeSH
- Antineoplastic Agents * MeSH
We previously demonstrated that alkyl gallates coupled to triphenylphosphine have a selective and efficient antiproliferative effect by inducing mitochondrial uncoupling in vitro due to the increased mitochondrial transmembrane potential of tumor cells. Therefore, in this work, the in vivo antitumor activities of alkyl gallate triphenylphosphonium derivatives (TPP+C8, TPP+C10 and TPP+C12) were evaluated in a syngeneic murine model of breast cancer. We found that TPP+C10 increased the cytosolic ADP/ATP ratio and significantly increased the AMP levels in a concentration-dependent manner in TA3/Ha murine mammary adenocarcinoma cells. Interestingly, TPP+C10 induced a decrease in the levels of cellular proliferation markers and promoted caspase-3 activation in tumor-bearing mice. Additionally, TPP+C10 inhibited tumor growth in the syngeneic mouse model. Importantly, 30days of intraperitoneal (i.p.) administration of the combination of TPP+C10 (10mg/kg/48h) and the antibiotic doxycycline (10mg/kg/24h) completely eliminated the subcutaneous tumor burden in mice (n=6), without any relapses at 60days post-treatment. This enhancement of the individual activities of TPP+C10 and doxycycline is due to the uncoupling of oxidative phosphorylation by TPP+C10 and the inhibition of mitochondrial biogenesis by doxycycline, as demonstrated by loss of mitochondrial mass and overexpression of PGC1-α as an adaptive response. Moreover, i.p. administration of TPP+C10 (10mg/kg/24h) to healthy mice did not produce toxicity or damage in organs important for drug metabolism and excretion, as indicated by hematological, biochemical and histological assessments. These findings suggest that the combination of TPP+C10 with doxycycline is a valuable candidate therapy for breast cancer management.
References provided by Crossref.org